Lurasidone for the treatment of schizophrenia: pooled analysis of short-term, placebo-controlled trials

被引：0
|
作者：
Murthy, V. [1 ]
Cucchiaro, J. [2 ]
Pikalov, A. [3 ]
Xu, J. [2 ]
Loebel, A. [3 ]
机构：
[1] Takeda Dev Ctr Europe, Clin Dev, London, England
[2] Sunovion Pharmaceut Inc, Clin Dev, Ft Lee, NJ 07024 USA
[3] Sunovion Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ 07024 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70769-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.046
引用
下载
收藏
页码：S485 / S486
页数：2
相关论文
共 50 条
  • [31] EFFECT OF LURASIDONE ON NEUROCOGNITIVE PERFORMANCE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS FROM A PLACEBO-CONTROLLED SHORT-TERM STUDY AND AN OPEN-LABEL EXTENSION STUDY
    Harvey, Philip D.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S175 - S176
  • [32] The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis
    A DeFelice
    J Willard
    J Lawrence
    J Hung
    M A Gordon
    A Karkowsky
    S Targum
    D C Throckmorton
    J Girton
    B Stertz
    S P Glasser
    R J Lipicky
    Journal of Human Hypertension, 2008, 22 : 659 - 668
  • [33] The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis
    DeFelice, A.
    Willard, J.
    Lawrence, J.
    Hung, J.
    Gordon, M. A.
    Karkowsky, A.
    Targum, S.
    Throckmorton, D. C.
    Girton, J.
    Stertz, B.
    Glasser, S. P.
    Lipicky, R. J.
    JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (10) : 659 - 668
  • [34] Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials (vol 103, pg 244, 2018)
    Zheng, Wei
    Cai, Dong-Bin
    Yang, Xin-Hu
    Li, Lu
    Zhang, Qing-E.
    Ng, Chee H.
    Ungvari, Gabor S.
    Li, Xian-Bin
    Ning, Yu-Ping
    Xiang, Yu-Tao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 105 : 54 - 54
  • [35] Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Praksh S.
    Serretti, Alessandro
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2015, 40 (03): : 174 - 186
  • [36] Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials
    Citrome, Leslie
    Meng, Xiangyi
    Hochfeld, Marla
    Stahl, Stephen M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (01) : 24 - 32
  • [37] Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
    Pae, Chi-Un
    Patkar, Ashwin A.
    Jang, Saeheon
    Portland, Kimberly B.
    Jung, Sungwon
    Nelson, J. Craig
    CNS SPECTRUMS, 2014, 19 (04) : 324 - 329
  • [38] Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials
    Buckley, PF
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1357 - 1363
  • [39] Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions
    Zhou, Yanchen
    Zhang, Feng
    Manning, Marta Starcevic
    Hu, Zheng
    Hsu, Cheng-Pang
    Chen, Po-Wei
    Peng, Cheng
    Loop, Brett
    Mytych, Daniel T.
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2022, 42 (08) : 749 - 760
  • [40] Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
    Kaiser, L
    Henry, D
    Flack, NP
    Keene, O
    Hayden, FG
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 587 - 589
12345